cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene

C64H106F2N12O6 — CID 171627759

IUPACcyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene
SMILESC1CCCCC1.CC1(C)CCN(Cc2cc(F)c(N3CC(=O)NC4(CCN(c5cc(N6CCCC6)ncn5)CC4)C3)cc2F)CC1.CCC.CNC(=O)CO.CNC(C)C.NC=O.O=CNCC(=O)N1CCCC1.c1ccc2c(c1)CCCC2
InChIInChI=1S/C30H41F2N7O.C10H12.C7H12N2O2.C6H12.C4H11N.C3H7NO2.C3H8.CH3NO/c1-29(2)5-11-36(12-6-29)18-22-15-24(32)25(16-23(22)31)39-19-28(40)35-30(20-39)7-13-38(14-8-30)27-17-26(33-21-34-27)37-9-3-4-10-37;1-2-6-10-8-4-3-7-9(10)5-1;10-6-8-5-7(11)9-3-1-2-4-9;1-2-4-6-5-3-1;1-4(2)5-3;1-4-3(6)2-5;1-3-2;2-1-3/h15-17,21H,3-14,18-20H2,1-2H3,(H,35,40);1-2,5-6H,3-4,7-8H2;6H,1-5H2,(H,8,10);1-6H2;4-5H,1-3H3;5H,2H2,1H3,(H,4,6);3H2,1-2H3;1H,(H2,2,3)
InChIKeyZMZBFAKECKAENE-UHFFFAOYSA-N
MW1177.63 g/mol
LogP8.07
Rot. Bonds10

About cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene

cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene (PubChem CID 171627759) has the molecular formula C64H106F2N12O6 and a molecular weight of 1177.63 g/mol. Its IUPAC name is cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene.

Molecular Properties

Compound Namecyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene
PubChem CID171627759
Molecular FormulaC64H106F2N12O6
Molecular Weight1177.63 g/mol
Exact Mass1176.83
IUPAC Namecyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene
SMILESC1CCCCC1.CC1(C)CCN(Cc2cc(F)c(N3CC(=O)NC4(CCN(c5cc(N6CCCC6)ncn5)CC4)C3)cc2F)CC1.CCC.CNC(=O)CO.CNC(C)C.NC=O.O=CNCC(=O)N1CCCC1.c1ccc2c(c1)CCCC2
InChIInChI=1S/C30H41F2N7O.C10H12.C7H12N2O2.C6H12.C4H11N.C3H7NO2.C3H8.CH3NO/c1-29(2)5-11-36(12-6-29)18-22-15-24(32)25(16-23(22)31)39-19-28(40)35-30(20-39)7-13-38(14-8-30)27-17-26(33-21-34-27)37-9-3-4-10-37;1-2-6-10-8-4-3-7-9(10)5-1;10-6-8-5-7(11)9-3-1-2-4-9;1-2-4-6-5-3-1;1-4(2)5-3;1-4-3(6)2-5;1-3-2;2-1-3/h15-17,21H,3-14,18-20H2,1-2H3,(H,35,40);1-2,5-6H,3-4,7-8H2;6H,1-5H2,(H,8,10);1-6H2;4-5H,1-3H3;5H,2H2,1H3,(H,4,6);3H2,1-2H3;1H,(H2,2,3)
InChIKeyZMZBFAKECKAENE-UHFFFAOYSA-N
XLogP8.07
TPSA221.70 Ų
H-Bond Donors6
H-Bond Acceptors13
Rotatable Bonds10
Heavy Atoms84
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001177.63
LogP ≤ 58.07
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_D(198)', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene?
The IUPAC name of cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene (CID 171627759) is cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene.
What is the SMILES notation for cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene?
The canonical SMILES for cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene is C1CCCCC1.CC1(C)CCN(Cc2cc(F)c(N3CC(=O)NC4(CCN(c5cc(N6CCCC6)ncn5)CC4)C3)cc2F)CC1.CCC.CNC(=O)CO.CNC(C)C.NC=O.O=CNCC(=O)N1CCCC1.c1ccc2c(c1)CCCC2.
What is the InChIKey of cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene?
The InChIKey is ZMZBFAKECKAENE-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H41F2N7O.C10H12.C7H12N2O2.C6H12.C4H11N.C3H7NO2.C3H8.CH3NO/c1-29(2)5-11-36(12-6-29)18-22-15-24(32)25(16-23(22)31)39-19-28(40)35-30(20-39)7-13-38(14-8-30)27-17-26(33-21-34-27)37-9-3-4-10-37;1-2-6-10-8-4-3-7-9(10)5-1;10-6-8-5-7(11)9-3-1-2-4-9;1-2-4-6-5-3-1;1-4(2)5-3;1-4-3(6)2-5;1-3-2;2-1-3/h15-17,21H,3-14,18-20H2,1-2H3,(H,35,40);1-2,5-6H,3-4,7-8H2;6H,1-5H2,(H,8,10);1-6H2;4-5H,1-3H3;5H,2H2,1H3,(H,4,6);3H2,1-2H3;1H,(H2,2,3).
What are the key properties of cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene?
cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene has a molecular weight of 1177.63 g/mol, XLogP of 8.07, 10 rotatable bonds, 6 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for cyclohexane;4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2,5-difluorophenyl]-9-(6-pyrrolidin-1-ylpyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one;formamide;2-hydroxy-N-methylacetamide;N-methylpropan-2-amine;N-(2-oxo-2-pyrrolidin-1-ylethyl)formamide;propane;1,2,3,4-tetrahydronaphthalene is sourced from PubChem (CID 171627759), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).